Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue, net $ 411,000 $ 465,000
Cost of revenue 348,000 407,000
Gross profit 63,000 58,000
Operating Expenses:    
Research and development 1,134,000 1,361,000
Sales and marketing 698,000 749,000
General and administrative 891,000 615,000
Total operating expenses 2,723,000 2,725,000
Loss from operations (2,660,000) (2,667,000)
Interest expense (37,000) 0
Change in fair value of warrant liability 19,000 111,000
Change in fair value of derivative liability 19,000 111,000
Other income (expense), net (2,000) (3,000)
Loss before provision for income taxes (2,680,000) (2,559,000)
Provision for income taxes 0 6,000
Net loss (2,680,000) (2,565,000)
Convertible preferred stock dividend (20,000) 0
Net loss attributable to common stockholders $ (2,700,000) $ (2,565,000)
Net loss per common share - basic and diluted $ (2.19) $ (3.33)
Weighted average number of common shares used in computing net loss per common share 1,230,598 770,381